Eczema in early childhood increases the risk of allergic multimorbidity

L A Miltner1, J M Vonk2,3, J L van der Velde3,4

  • 1Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

PubMed

Insights

Early-onset persistent eczema significantly increases the risk of developing food allergy, asthma, and hay fever in children. Identifying infants at risk is crucial for preventing allergic multimorbidity.

Area of Science:

  • Pediatric Allergy and Immunology
  • Dermatology
  • Epidemiology

Background:

  • Early childhood eczema is linked to later allergic diseases like food allergy (FA), asthma, and hay fever.
  • Eczema presentation varies, influencing allergic outcomes.
  • Eczema sub-phenotypes may predict allergic multimorbidity.

Purpose of the Study:

  • To associate eczema phenotypes with FA, asthma, and hay fever in children/adolescents.
  • To describe disease trajectories stratified by FA presence.

Main Methods:

  • Utilized the TRACKER cohort study (n=6852).
  • Investigated seven eczema phenotypes based on onset and persistence.
  • Employed logistic regression and calculated disease prevalence at different ages.

Main Results:

  • Persistent eczema throughout childhood elevated risks for FA, hay fever, and asthma.
  • "Very early onset-persistent" eczema showed the strongest associations.
  • FA presence correlated with significantly higher prevalence of eczema, asthma, and hay fever across all ages.

Conclusions:

  • This large cohort study confirms that early-onset, persistent eczema heightens the risk of allergic multimorbidity.
  • Early identification of infants susceptible to very early-onset eczema is vital for prevention strategies.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Allergic Reactions02:06

Allergic Reactions

Overview
27.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K